CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 74-89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Please refer to our Risk Disclosure Statement
Open platformOpen platform

MediWound Prices $17.25 Million Share Offering at $12.50 Per Share

By Public Technologies
  • MediWound priced a follow-on offering of 1,200,000 ordinary shares at $12.50 per share.
  • H.C. Wainwright exercised its option for 180,000 additional ordinary shares in full on November 4, 2026.
  • Gross proceeds, including the option shares, are expected to total approximately $17.25 million before underwriting discounts and offering expenses.
  • The offering is expected to close on or about November 5, 2026, subject to customary closing conditions.
  • Net proceeds will primarily fund working capital and general corporate purposes.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MediWound Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001178913-26-005046), on November 05, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk